Skip to main content
Clinical Trials/CTRI/2024/03/063492
CTRI/2024/03/063492
Not yet recruiting
Phase 1

eutrophil Lymphocyte Platelet Ratio As A Prognostic Marker In Critically Ill Patient Admitted In Medical Intensive Care Unit At Rural Set Up

Datta Meghe Institute Of Higher Education And Research0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
Datta Meghe Institute Of Higher Education And Research
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Datta Meghe Institute Of Higher Education And Research

Eligibility Criteria

Inclusion Criteria

  • 1\.Consenting Patients
  • 2\.All patients admitted in Medical Intensive Care Unit who are critically ill on the basis if APACHE IV criteria

Exclusion Criteria

  • 1\.Non Consenting Patients
  • 2\.Patients undergoing anti platelet treatment
  • 3\.Patients refusing investigations
  • 4\.Pregnancy
  • 5\.Death of Patient within 24 hrs of hospital stay

Outcomes

Primary Outcomes

Not specified

Similar Trials